Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Christopher W MangieriCristian D ValenzuelaIan B SolskyRichard A EraliKonstantinos I VotanopoulosPerry ShenEdward A Levine

Published in: Journal of surgical oncology (2022)

Myometrium invasion is a significant negative prognostic factor for survival following CRS-HIPEC. Several risk factors are potentially predictive of identifying those at high-risk for myometrium invasion.

Keyphrases

cell migration
prognostic factors
risk factors
minimally invasive
free survival
squamous cell carcinoma